From IPM Products Manufacturing, Inc.
For Further Information: Contact Donald Richardson at email@example.com
IPM Product Manufacturing Appoints Dr. Ron Hart To Advisory Council; Internationally Recognized Scientist To Advise on Mosquito Control & Combating Zika Threat;
Little Rock, AR, August 1, 2016 – IPM Product Manufacturing, Inc. (IPM) announced today that Ronald W. Hart, Ph.D. has been appointed to the Company’s scientific advisory council. Dr. Hart’s appointment coincides with the Company’s roll-out of its first generation SolaRidTM Integrated Pest Management solution. Dr. Hart brings a distinguished 40-year career in business and science to IPM. He has held senior appointments in the Reagan, Bush and Clinton administrations, serving as Chief Scientist and Executive Director of the FDA’s National Center for Toxicological Research (NCTR) from 1980 to 1992 and Distinguished Scientist in Residence for the Public Health Service/FDA from 1992 to 2000.
Concerning the appointment of Dr. Hart, IPM CEO Randy Sasaki said, “We are proud to add Dr. Ron Hart to our advisory council. He is an internationally recognized scientist, scholar, and expert in business acceleration strategies for emerging growth companies. He holds a Ph.D. in Physiology and Biophysics from the University of Illinois. Dr. Hart’s business counsel and his scientific acumen are both invaluable assets to IPM as we engage potential buyers of the SolaRidTM device in the areas of government, business and agriculture.”
Dr. Hart Affirms the Science of the SolaRidTM Device
According to Dr. Hart, “In light of the current Zika virus threat, I feel proud to assist IPM Product Manufacturing in making an important contribution to the fight to contain the Zika virus via vector control. SolaRid™’s proprietary OS effectively manages a combination of proven attractants in a way unlike any other insect control device I have seen. I look forward to working with the researchers and universities that are currently providing field testing data which we will use to improve the current device and each subsequent product update.”
IPM PRODUCT MANUFACTURING, INC.
IPM Products Manufacturing, Inc. has developed a groundbreaking product to control and kill mosquitoes and other flying insects. This device, called SolaRidTM, is a safe and effective alternative to chemicals used in the vast global insecticide industry. The insect control unit’s combination of technologies has proven to be extremely effective in controlling insect infestations.
The Company has developed two models; the first, used in Agriculture, operates 12 hours each day. The second, used in urban environments, operates 24 / 7. Both are effective by luring insects by use of three proprietary sensory outputs. The light, sound and scent outputs target the inescapable, natural susceptibilities of insects and the intelligently staged release of the attractants allow for each to have maximum impact within their effective range.
The Company is currently selling equity to finance the build-out of inventory necessary to meet the expected order flow. Information about the offering is available by contacting David McCarthy at firstname.lastname@example.org, 917-974-9872.
CONTACT IPM PRODUCT MANUFACTURING FOR MORE INFORMATION
For more information on purchasing the SolaRidTM device, the product technology and/or the Company, please contact: Randy Sasaki at email@example.com
IPM Product Manufacturing
PO Box 102973
Denver, CO, 80250
“Safe Harbor” Statement:
The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products in development and any other statements not constituting historical facts are “forward-looking statements,” within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company’s actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company’s operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company’s SEC filings, which could cause the company’s actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.